Time course evaluation of myocardial perfusion after reperfusion therapy by 99mTc-tetrofosmin SPECT in patients with acute myocardial infarction

Journal of Nuclear Medicine

Volumn 42, Issue 9, 2001, Pages 1351-1358

  Tanaka, R ^a   Nakamura, T ^a  

^a Kushiroshi Ishikai Hospital   (Japan)

Author keywords

123I BMIPP; 99mTc tetrofosmin; Acute myocardial infarction; Percutaneous transluminal coronary angioplasty; Reperfusion

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; TETROFOSMIN TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; QUANTITATIVE GENETICS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FATTY ACIDS; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0034849973     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells
2. Physiological basis of myocardial perfusion imaging with the technetium-99m agents
3. 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction
4. Thrombolytic therapy for myocardial infarction: Assessment of efficacy by myocardial perfusion imaging with technetium-99m sestamibi
5. Detection and assessment of unstable angina using myocardial perfusion imaging: Comparison between technetium-99m sestamibi SPECT and 12-lead electrocardiogram
6. 99mTc-sestamibi SPECT in acute myocardial infarction following direct PTCA
7. Reverse redistribution of Tc-99m-tetrofosmin in patients with acute myocardial infarction
8. 123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism
9. Newly developed myocardial imaging by using single photon computed tomography (SPECT)
10. 123I-labeled beta-methyl-iodophenyl pentadecanoic acid in ischemic heart disease
11. Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury
12. 99mTc-sestamibi
13. Detecting myocardial salvage after primary PTCA: Early myocardial contrast echocardiography versus delayed sestamibi perfusion imaging
14. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography
15. Timing of coronary recanalization: Paradigms, paradoxes, and pertinence
16. Prevention of left ventricular remodeling by percutaneous transluminal coronary angioplasty performed 24 hours after the onset of acute myocardial infarction
17. Predicting late restenosis after coronary angioplasty by very early (12 to 24 h) thallium-201 scintigraphy: Implications with regard to mechanisms of late coronary restenosis
18. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: Delayed resolution of exercise-induced scintigraphic abnormalities
19. Current status of myocardial perfusion imaging after percutaneous transluminal coronary angioplasty
20. Stress thallium-201 imaging after coronary angioplasty predicts restenosis and recurrent symptoms
21. Differences of regional coronary flow reserve assessed by adenosine thallium-201 scintigraphy early and six months after successful percutaneous transluminal coronary angioplasty or STENT implantation
22. Reverse redistribution of thallium-201: A sign of nontransmural myocardial infarction with patency of the infarct-related coronary artery
23. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction
24. Mechanism of uptake of technetium-tetrofosmin. I. Uptake into isolated adult rat ventricular myocytes and subcellular localization
25. Mechanism of uptake technetium-tetrofosmin. II. Uptake into isolated adult rat heart mitochondria
26. Myocardial accumulation of iodine beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP), in relation to ATP concentration
27. Back diffusion of BMIPP plays an important role in perfusion/metabolism mismatch on SPECT images with ischemia
28. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium
29. Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir
30. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using branched fatty acid analog
31. Myocardial emission computed tomography with iodine-123-labeled-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy
32. 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy
33. 125I-BMIPP in rats treated with adriamycin
34. 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction
35. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact
36. 99mTc-tetrofosmin myocardial SPECT
37. Role of glycolytic products in damage to ischemic myocardium: Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts
38. 123I-BMIPP imaging cardiac function in acute myocardial infarction
39. 123I-β-methyl iodophenyl of infarcted myocardium
40. 123I-labeled beta-methyl-iodophenyl pentadecanoic acid in ischemic heart disease